Home › Researcher directory › Hassan Errrihani
Hassan Errrihani
Affiliation : Mohammed V University · Centre Hospitalier Ibn Sina · Institut National d'Oncologie
- 3Publications (affiliation in Morocco)
- 3Total publications
- 4Citations
- 1h-index
Research profile
Hassan Errrihani has 3 indexed publications (2015). Their work appears mainly in “Pan African Medical Journal” and “DOAJ (DOAJ: Directory of Open Access Journals)”. Their most cited article, “Participation du patient Marocain atteint du cancer au choix thérapeutique: résultat d’une enquête réalisée auprès de 272 patients” (2015), has been cited 2 times. Their work is co-authored with at least 7 researchers.
Is this you? Get your research seen
Create your free DzCademia profile and add your articles: they will show up more easily on Google and in AI assistants like ChatGPT, so more people can read and cite your work.
Create my free profile Add my publicationsResearch areas
- Palliative Care and End-of-Life Issues
- Lung Cancer Diagnosis and Treatment
- Thyroid Cancer Diagnosis and Treatment
- Health Systems, Economic Evaluations, Quality of Life
- Patient-Provider Communication in Healthcare
Publications (3)
- Participation du patient Marocain atteint du cancer au choix thérapeutique: résultat d’une enquête réalisée auprès de 272 patients
- Le coût par QALY rapporté au PIB (CQP): suggestion d'un nouvel indice économique évaluant l'impact réel du coût du bénéfice des molécules onéreuses en oncologie par rapport aux moyens économique d'un pays
- Une métastase intra-thyroïdienne révélant un cancer bronchique non à petites cellules
Publication venues
- Pan African Medical Journal × 2
- DOAJ (DOAJ: Directory of Open Access Journals) × 1
Co-authors
Bibliographic data from OpenAlex (open database).
Why choose Dzcademia?
Profiles, articles and conference contributions: give your research a structured public presence. Integrated metadata help search engines and AI assistants identify your work and understand its references.
Comment with Google
Sign in with Google to comment directly on this page.